A Phase II Study of Dexamethasone (DECADRON), Clarithromycin (BIAXIN), and Pomalidomide (CC-4047) for Subjects With Relapsed or Refractory Multiple Myeloma.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 20 Jul 2017
At a glance
- Drugs Pomalidomide (Primary) ; Clarithromycin; Dexamethasone
- Indications Multiple myeloma
- Focus Registrational; Therapeutic Use
- 13 Feb 2017 Planned number of patients changed from 54 to 121.
- 13 Feb 2017 Planned End Date changed from 1 Jun 2013 to 1 Jun 2020.
- 13 Feb 2017 Status changed from recruiting to active, no longer recruiting.